Roberta Rossini

Summary

Country: Italy

Publications

  1. doi request reprint Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation
    Roberta Rossini
    Divisione di Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Am J Cardiol 101:786-9. 2008
  2. doi request reprint Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents
    Roberta Rossini
    USC Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Largo Barozzi 1, Bergamo, Italy
    Expert Rev Pharmacoecon Outcomes Res 10:49-61. 2010
  3. doi request reprint Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease
    Roberta Rossini
    USC Cardiologia, Dipartimento Cardiovascolare, AO Ospedale Papa Giovanni XXIII, Bergamo, Italy
    Am J Cardiol 112:150-5. 2013
  4. doi request reprint [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation]
    Roberta Rossini
    Departimento Cardiovascolare, Ospedali Riuniti, Bergamo
    G Ital Cardiol (Rome) 13:528-51. 2012
  5. ncbi request reprint Prevention of left ventricular remodelling after acute myocardial infarction: an update
    Roberta Rossini
    Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Recent Pat Cardiovasc Drug Discov 5:196-207. 2010
  6. doi request reprint Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy
    Roberta Rossini
    Divisione di Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Am J Cardiol 102:1618-23. 2008
  7. doi request reprint Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation
    Roberta Rossini
    Cardiovascular Department, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Coron Artery Dis 22:199-205. 2011
  8. doi request reprint Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation
    Roberta Rossini
    USC Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Italy
    Am J Cardiol 107:186-94. 2011
  9. doi request reprint Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation
    Giuseppe Musumeci
    USC Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Catheter Cardiovasc Interv 80:395-405. 2012
  10. doi request reprint Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial
    Luigi Fiocca
    Cardiovascular Department, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Am J Cardiol 111:196-201. 2013

Detail Information

Publications19

  1. doi request reprint Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation
    Roberta Rossini
    Divisione di Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Am J Cardiol 101:786-9. 2008
    ..In conclusion, rapid desensitization is safe and highly effective in patients with aspirin sensitivity and coronary artery disease who undergo coronary stent implantation, including those who receive drug-eluting stents...
  2. doi request reprint Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents
    Roberta Rossini
    USC Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Largo Barozzi 1, Bergamo, Italy
    Expert Rev Pharmacoecon Outcomes Res 10:49-61. 2010
    ..However, data are not consistent and concerns remain...
  3. doi request reprint Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease
    Roberta Rossini
    USC Cardiologia, Dipartimento Cardiovascolare, AO Ospedale Papa Giovanni XXIII, Bergamo, Italy
    Am J Cardiol 112:150-5. 2013
    ..Only 50% of patients with nonobstructive CAD were prescribed dual antiplatelet therapy. In conclusion, patients with ACS and nonobstructive CAD remain at high risk of long-term recurrent ischemic events. ..
  4. doi request reprint [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation]
    Roberta Rossini
    Departimento Cardiovascolare, Ospedali Riuniti, Bergamo
    G Ital Cardiol (Rome) 13:528-51. 2012
    ....
  5. ncbi request reprint Prevention of left ventricular remodelling after acute myocardial infarction: an update
    Roberta Rossini
    Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Recent Pat Cardiovasc Drug Discov 5:196-207. 2010
    ..e. stem cell transfer, activation of cardiac and leukocyte-dependent oxidant stress pathways, inflammatory pathway activation, matrix-metalloproteinase activation...
  6. doi request reprint Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy
    Roberta Rossini
    Divisione di Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Am J Cardiol 102:1618-23. 2008
    ..8% vs 4.9%, p = 0.7). In conclusion, in patients undergoing coronary stenting on triple therapy, targeting lower therapeutic INR values reduces the risk of bleeding complications...
  7. doi request reprint Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation
    Roberta Rossini
    Cardiovascular Department, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Coron Artery Dis 22:199-205. 2011
    ..However, data from clinical studies are conflicting. The aim of this study was to evaluate the safety of long-term clopidogrel and PPI therapy...
  8. doi request reprint Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation
    Roberta Rossini
    USC Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Italy
    Am J Cardiol 107:186-94. 2011
    ..2% vs 3.2%, p = 0.275). In conclusion, premature discontinuation of antiplatelet therapy is relatively common, especially within the first year, and strongly associated with increased cardiovascular events, including ST and death...
  9. doi request reprint Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation
    Giuseppe Musumeci
    USC Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Catheter Cardiovasc Interv 80:395-405. 2012
    ..However, the prevalence and predictors of long-term bleeding events in patients on prolonged dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation has been poorly explored...
  10. doi request reprint Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial
    Luigi Fiocca
    Cardiovascular Department, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Am J Cardiol 111:196-201. 2013
    ..The excluded patients had a significantly greater risk profile and markedly increased mortality and adverse events compared to the trial-eligible group...
  11. doi request reprint Optical coherence tomography in ST-elevation myocardial infarction treated with novel drug-eluting stent: preprocedural, postimplant and 2-month follow-up findings
    Vasile Sirbu
    Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy
    J Cardiovasc Med (Hagerstown) 12:55-8. 2011
    ..Using OCT and IVUS, we evaluated the intravascular morphology of the culprit vessel, the acute and intermediate result of novel DES implanted to treat an ST-segment elevation myocardial infarction...
  12. ncbi request reprint Safety and feasibility of transradial coronary angioplasty in elderly patients
    Orazio Valsecchi
    Interventional Catheterization Laboratory Cardiovascular Department, Ospedali Riuniti, Bergamo, Italy
    Ital Heart J 5:926-31. 2004
    ..The aim of this study was to assess the safety, feasibility and efficacy of transradial coronary angioplasty in elderly (> or = 70 years) vs younger patients (< 70 years)...
  13. ncbi request reprint Antiplatelet therapy in patients undergoing coronary stent implantation: Italian Society of Interventional Cardiology consensus document
    Giulio Guagliumi
    Cardiovascular Department, Ospedali Riuniti di Bergamo, Italy
    J Cardiovasc Med (Hagerstown) 8:782-91. 2007
    ..However, the combination of delayed healing with DES and the increasing complexity of the stent implantation raises more demanding safety concerns about the dosage and duration of dual antiplatelet therapy...
  14. doi request reprint Oral antiplatelet therapy after drug-eluting stent implantation: adherence and side-effects
    Roberta Rossini
    aDipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo bDipartimento Cardiovascolare, Ospedale Niguarda Ca Granda, Milan, Italy
    J Cardiovasc Med (Hagerstown) 14:81-90. 2013
    ..Furthermore, pharmacological interactions (e.g. proton pump inhibitors) as well as other causes of drug discontinuation will be addressed, particularly focusing on their prognostic and practical implications...
  15. ncbi request reprint GP IIb/IIIa inhibitors for STEMI: still the gold standard or an old survivor?
    Giuseppe Musumeci
    Cardiovascular Department, Ospedali Riuniti di Bergamo, Largo Barozzi 1, Bergamo, Italy
    Curr Vasc Pharmacol 10:443-7. 2012
    ..In this review, a risk/benefit evaluation GP IIb\IIIa inhibitors is presented and their indications for STEMI patients addressed to revascularization are discussed according to recent advances reported in literature...
  16. pmc Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions
    Roberta Rossini
    USC Cardiologia, Dipartimento Cardiovascolare, Ospedale Papa Giovanni XXIII Bergamo, Italy
    Am J Cardiovasc Dis 3:27-38. 2013
    ....
  17. ncbi request reprint Failure of transradial approach during coronary interventions: anatomic considerations
    Orazio Valsecchi
    Interventional Cath Lab, Cardiovascular Department, Ospedali Riuniti of Bergamo, Italia
    Catheter Cardiovasc Interv 67:870-8. 2006
    ..Anatomic variations of the radial artery are not rare. However, they do not represent an important limitation in transradial approach if they are well documented previously...
  18. ncbi request reprint [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur]
    Roberta Rossini
    Ital Heart J Suppl 6:621-6. 2005
  19. ncbi request reprint Safety, feasibility, and six-month outcomes of a systematic strategy of direct coronary stenting by a transradial approach in patients with single-vessel disease
    Giovanni Amoroso
    Cardio Thoracic Department, University of Pisa, Italy
    Ital Heart J 5:22-8. 2004
    ..We sought to evaluate the safety, feasibility, and long-term outcomes of a systematic strategy of coronary stenting without predilation (direct stenting) via a transradial approach for single-vessel procedures...